Bristol-Myers Squibb Company(BMY)
📊 Dividend Highlights
Previous Payout History
86 payouts shown| Pay Date | Amount Per Share | Change vs Previous |
|---|---|---|
| May 1, 2025 | $0.62 | - |
| February 3, 2025 | $0.62 | ▲3.33% |
| November 1, 2024 | $0.60 | - |
| August 1, 2024 | $0.60 | - |
| May 1, 2024 | $0.60 | - |
| February 1, 2024 | $0.60 | ▲5.26% |
| November 1, 2023 | $0.57 | - |
| August 1, 2023 | $0.57 | - |
| May 1, 2023 | $0.57 | - |
| February 1, 2023 | $0.57 | ▲5.56% |
| November 1, 2022 | $0.54 | - |
| August 1, 2022 | $0.54 | - |
| May 2, 2022 | $0.54 | - |
| February 1, 2022 | $0.54 | ▲10.20% |
| November 1, 2021 | $0.49 | - |
| August 2, 2021 | $0.49 | - |
| May 3, 2021 | $0.49 | - |
| February 1, 2021 | $0.49 | ▲8.89% |
| November 2, 2020 | $0.45 | - |
| August 3, 2020 | $0.45 | - |
| May 1, 2020 | $0.45 | - |
| February 3, 2020 | $0.45 | ▲9.76% |
| November 1, 2019 | $0.41 | - |
| August 1, 2019 | $0.41 | - |
| May 1, 2019 | $0.41 | - |
| February 1, 2019 | $0.41 | ▲2.50% |
| November 1, 2018 | $0.40 | - |
| August 1, 2018 | $0.40 | - |
| May 1, 2018 | $0.40 | - |
| February 1, 2018 | $0.40 | ▲2.56% |
| November 1, 2017 | $0.39 | - |
| August 1, 2017 | $0.39 | - |
| May 1, 2017 | $0.39 | - |
| February 1, 2017 | $0.39 | ▲2.63% |
| November 1, 2016 | $0.38 | - |
| August 1, 2016 | $0.38 | - |
| May 2, 2016 | $0.38 | - |
| February 1, 2016 | $0.38 | ▲2.70% |
| November 2, 2015 | $0.37 | - |
| August 3, 2015 | $0.37 | - |
| May 1, 2015 | $0.37 | - |
| February 2, 2015 | $0.37 | ▲2.78% |
| November 3, 2014 | $0.36 | - |
| August 1, 2014 | $0.36 | - |
| May 1, 2014 | $0.36 | - |
| February 3, 2014 | $0.36 | ▲2.86% |
| November 1, 2013 | $0.35 | - |
| August 1, 2013 | $0.35 | - |
| May 1, 2013 | $0.35 | - |
| February 1, 2013 | $0.35 | ▲2.94% |
| November 1, 2012 | $0.34 | - |
| August 1, 2012 | $0.34 | - |
| May 1, 2012 | $0.34 | - |
| February 1, 2012 | $0.34 | ▲3.03% |
| November 1, 2011 | $0.33 | - |
| August 1, 2011 | $0.33 | - |
| May 2, 2011 | $0.33 | - |
| February 1, 2011 | $0.33 | ▲3.13% |
| November 1, 2010 | $0.32 | - |
| August 2, 2010 | $0.32 | - |
| May 3, 2010 | $0.32 | - |
| February 1, 2010 | $0.32 | ▲3.23% |
| November 2, 2009 | $0.31 | - |
| August 3, 2009 | $0.31 | - |
| May 1, 2009 | $0.31 | - |
| February 2, 2009 | $0.31 | - |
| November 3, 2008 | $0.31 | - |
| August 1, 2008 | $0.31 | - |
| May 1, 2008 | $0.31 | - |
| February 1, 2008 | $0.31 | ▲10.71% |
| November 1, 2007 | $0.28 | - |
| August 1, 2007 | $0.28 | - |
| May 1, 2007 | $0.28 | - |
| February 1, 2007 | $0.28 | - |
| November 1, 2006 | $0.28 | - |
| August 1, 2006 | $0.28 | - |
| May 1, 2006 | $0.28 | - |
| February 1, 2006 | $0.28 | - |
| November 1, 2005 | $0.28 | - |
| August 1, 2005 | $0.28 | - |
| May 2, 2005 | $0.28 | - |
| February 1, 2005 | $0.28 | - |
| November 1, 2004 | $0.28 | - |
| August 2, 2004 | $0.28 | - |
| May 3, 2004 | $0.28 | - |
| February 2, 2004 | $0.28 |
Overall Dividend Trend
Dividend per share has changed by+121.43%over the past 21years(comparing first and last payout shown).
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company, often abbreviated as BMS, is a globally recognized pharmaceutical company known for its cutting-edge research and development in the biopharmaceutical sector. Founded in 1858 by Edward Robinson Squibb, the company was later shaped by a significant merger in 1989 with Bristol-Myers, which was established in 1887 by William McLaren Bristol and John Ripley Myers. Headquartered in New York City, BMS focuses on developing innovative medicines to combat serious illnesses in areas such as oncology, immunology, cardiovascular health, and fibrosis. As of 2022, the company's revenue exceeded $46 billion, underlining its substantial impact on health care and its role as a leader in the industry. BMS is particularly known for its strong pipeline of medications and its commitment to investing in cutting-edge scientific research. The company's approach combines internal innovation with key acquisitions and partnerships to enhance its portfolio and reach. This commitment to innovation and collaboration has made BMS a pivotal player in the global pharmaceutical landscape, dedicated to transforming patients’ lives through science.
Apple Inc.(AAPL)
Microsoft Corporation(MSFT)
Johnson & Johnson(JNJ)
Procter & Gamble Co.(PG)
Coca-Cola Co.(KO)
PepsiCo, Inc.(PEP)
Exxon Mobil Corporation(XOM)
Verizon Communications Inc.(VZ)
AT&T Inc.(T)
Chevron Corporation(CVX)Dividend data last updated:Tue, 20 May 2025 19:33:10 GMT. Financial data is indicative and provided for informational purposes only.